Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Civitelli

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2005
Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesionChan Soo Shin, Sun-Ju Her, Jeong-Ah Kim, et al.
Metabolism: Clinical and Experimental|January 10, 2026
Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strengthGiulia Leanza, Malak Faraj, Francesca Cannata, et al.
The Journal of Rheumatology|February 9, 2008
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA studyJohn A Eisman, Roberto Civitelli, Silvano Adami, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronateJean-Yves Reginster, Dieter Felsenberg, Cyrus Cooper, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Arthritis and Rheumatism|May 27, 2006
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration studyPierre D Delmas, Silvano Adami, Cezary Strugala, et al.
Elife|April 10, 2024
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strengthGiulia Leanza, Francesca Cannata, Malak Faraj, et al.
Blood|April 14, 2012
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitorsDaniel Gonzalez-Nieto, Lina Li, Anja Kohler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2014
NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanismsChao Qu, Sheri L Bonar, Cynthia L Hickman-Brecks, et al.
JIMD Reports|November 15, 2024
Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L <i>GATM</i> variant and study of organoids towards treatmentIgnacio Portales-Castillo, Rhea Singal, Anastasia Ambrose, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2005
Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesionChan Soo Shin, Sun-Ju Her, Jeong-Ah Kim, et al.
Metabolism: Clinical and Experimental|January 10, 2026
Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strengthGiulia Leanza, Malak Faraj, Francesca Cannata, et al.
The Journal of Rheumatology|February 9, 2008
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA studyJohn A Eisman, Roberto Civitelli, Silvano Adami, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronateJean-Yves Reginster, Dieter Felsenberg, Cyrus Cooper, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Arthritis and Rheumatism|May 27, 2006
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration studyPierre D Delmas, Silvano Adami, Cezary Strugala, et al.
Elife|April 10, 2024
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strengthGiulia Leanza, Francesca Cannata, Malak Faraj, et al.
Blood|April 14, 2012
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitorsDaniel Gonzalez-Nieto, Lina Li, Anja Kohler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2014
NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanismsChao Qu, Sheri L Bonar, Cynthia L Hickman-Brecks, et al.
JIMD Reports|November 15, 2024
Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L <i>GATM</i> variant and study of organoids towards treatmentIgnacio Portales-Castillo, Rhea Singal, Anastasia Ambrose, et al.
Pageof 12